• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有神经保护活性的N-甲基-D-天冬氨酸受体通道阻滞剂。

An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity.

作者信息

Tai K K, Blondelle S E, Ostresh J M, Houghten R A, Montal M

机构信息

Section of Neurobiology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0366, USA.

出版信息

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3519-24. doi: 10.1073/pnas.061449498.

DOI:10.1073/pnas.061449498
PMID:11248110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC30685/
Abstract

Excitotoxicity, resulting from sustained activation of glutamate receptors of the N-methyl-d-aspartate (NMDA) subtype, is considered to play a causative role in the etiology of ischemic stroke and several neurodegenerative diseases. The NMDA receptor is therefore a target for the development of neuroprotective agents. Here, we identify an N-benzylated triamine (denoted as NBTA) as a highly selective and potent NMDA-receptor channel blocker selected by screening a reduced dipeptidomimetic synthetic combinatorial library. NBTA blocks recombinant NMDA receptors expressed in Xenopus laevis oocytes with a mean IC(50) of 80 nM; in contrast, it does not block GluR1, a glutamate receptor of the non-NMDA subtype. The blocking activity of NBTA on NMDA receptors exhibits the characteristics of an open-channel blocker: (i) no competition with agonists, (ii) voltage dependence, and (iii) use dependence. Significantly, NBTA protects rodent hippocampal neurons from NMDA receptor, but not kainate receptor-mediated excitotoxic cell death, in agreement with its selective action on the corresponding recombinant receptors. Mutagenesis data indicate that the N site, a key asparagine on the M2 transmembrane segment of the NR1 subunit, is the main determinant of the blocker action. The results highlight the potential of this compound as a neuroprotectant.

摘要

由N-甲基-D-天冬氨酸(NMDA)亚型谷氨酸受体的持续激活所导致的兴奋毒性,被认为在缺血性中风和几种神经退行性疾病的病因学中起致病作用。因此,NMDA受体是神经保护剂开发的一个靶点。在此,我们鉴定出一种N-苄基化三胺(记为NBTA),它是通过筛选一个简化的二肽模拟合成组合文库而选出的一种高选择性且强效的NMDA受体通道阻滞剂。NBTA阻断非洲爪蟾卵母细胞中表达的重组NMDA受体,平均半数抑制浓度(IC50)为80 nM;相比之下,它不阻断非NMDA亚型的谷氨酸受体GluR1。NBTA对NMDA受体的阻断活性表现出开放通道阻滞剂的特征:(i)不与激动剂竞争;(ii)电压依赖性;(iii)使用依赖性。重要的是,NBTA保护啮齿动物海马神经元免受NMDA受体介导的兴奋毒性细胞死亡,但不能保护其免受海人藻酸受体介导的兴奋毒性细胞死亡,这与其对相应重组受体的选择性作用一致。诱变数据表明,N位点是NR1亚基M2跨膜片段上的一个关键天冬酰胺,是该阻滞剂作用的主要决定因素。这些结果突出了该化合物作为神经保护剂的潜力。

相似文献

1
An N-methyl-D-aspartate receptor channel blocker with neuroprotective activity.一种具有神经保护活性的N-甲基-D-天冬氨酸受体通道阻滞剂。
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3519-24. doi: 10.1073/pnas.061449498.
2
A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity.一种具有体内神经保护活性的新型N-甲基-D-天冬氨酸受体开放通道阻滞剂。
J Pharmacol Exp Ther. 2002 Jul;302(1):163-73. doi: 10.1124/jpet.302.1.163.
3
Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.氟哌啶醇对N-甲基-D-天冬氨酸受体的亚型选择性抑制作用
Mol Pharmacol. 1996 Dec;50(6):1541-50.
4
Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.甲苯磺酰多胺衍生物通过抑制离子型谷氨酸受体实现神经保护作用。
J Pharmacol Exp Ther. 2009 Nov;331(2):522-30. doi: 10.1124/jpet.109.152926. Epub 2009 Jul 30.
5
Differential effects of linear and cyclic polyamines on NMDA receptor activities.线性和环状多胺对NMDA受体活性的不同影响。
Neurochem Int. 2008 Jul;53(1-2):38-44. doi: 10.1016/j.neuint.2008.04.009. Epub 2008 May 8.
6
The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons.在培养的海马神经元中,N-甲基-D-天冬氨酸受体的兴奋保护作用由脑源性神经营养因子自分泌环介导。
J Neurochem. 2005 Aug;94(3):713-22. doi: 10.1111/j.1471-4159.2005.03200.x. Epub 2005 Jul 5.
7
In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus.用钾离子通道阻滞剂4-氨基吡啶进行体内治疗,可通过激活小鼠海马体中的N-甲基-D-天冬氨酸受体,来保护机体免受海藻酸诱导的神经元细胞死亡。
Neuropharmacology. 2005 May;48(6):810-21. doi: 10.1016/j.neuropharm.2004.12.018.
8
Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons.胍丁胺可选择性阻断大鼠海马神经元中谷氨酸受体通道的N-甲基-D-天冬氨酸亚类。
J Pharmacol Exp Ther. 1999 Feb;288(2):544-9.
9
Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.喹喔啉衍生物:抑制N-甲基-D-天冬氨酸和非N-甲基-D-天冬氨酸受体介导的电流及突触电位的构效关系和生理意义
Mol Pharmacol. 1992 Feb;41(2):337-45.
10
N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.对映体6,7-苯并吗啡烷BIII 277 CL和BIII 281 CL对N-甲基-D-天冬氨酸受体通道的阻断作用
J Pharmacol Exp Ther. 1998 May;285(2):767-76.

引用本文的文献

1
Inhibition of N-methyl-D-aspartate-activated current by bis(7)-tacrine in HEK-293 cells expressing NR1/NR2A or NR1/NR2B receptors.在表达NR1/NR2A或NR1/NR2B受体的HEK-293细胞中,双(7)-他克林对N-甲基-D-天冬氨酸激活电流的抑制作用。
J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):793-797. doi: 10.1007/s11596-012-1036-0. Epub 2012 Dec 28.
2
Hypoxia associated NMDA receptor 2 subunit composition: developmental comparison between the hypoxia-tolerant subterranean mole-rat, Spalax, and the hypoxia-sensitive rat.缺氧相关的 NMDA 受体 2 亚基组成:耐缺氧的地下鼹形田鼠 Spalax 与缺氧敏感的大鼠之间的发育比较。
J Comp Physiol B. 2012 Oct;182(7):961-9. doi: 10.1007/s00360-012-0669-4. Epub 2012 May 11.
3
Idebenone induces apoptotic cell death in the human dopaminergic neuroblastoma SHSY-5Y cells.依地苯醌诱导人多巴胺能神经母细胞瘤 SHSY-5Y 细胞凋亡。
Neurotox Res. 2011 Nov;20(4):321-8. doi: 10.1007/s12640-011-9245-z. Epub 2011 May 3.
4
Pathologically activated neuroprotection via uncompetitive blockade of N-methyl-D-aspartate receptors with fast off-rate by novel multifunctional dimer bis(propyl)-cognitin.新型多功能二聚体丙基-认知素通过快速离解率的非竞争性 NMDA 受体阻断实现病理性神经保护作用。
J Biol Chem. 2010 Jun 25;285(26):19947-58. doi: 10.1074/jbc.M110.111286. Epub 2010 Apr 19.
5
Vpu matchmakers as a therapeutic strategy for HIV infection.Vpu配对分子作为一种治疗HIV感染的策略。
PLoS Pathog. 2009 May;5(5):e1000246. doi: 10.1371/journal.ppat.1000246. Epub 2009 May 29.
6
The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries.从组合文库中分离出的一种新型促黑素细胞激素1型(MCH1)受体拮抗剂的药理学特性。
Eur J Pharmacol. 2009 Jan 14;602(2-3):194-202. doi: 10.1016/j.ejphar.2008.10.068. Epub 2008 Nov 17.
7
Neuroprotection against excitotoxicity by N-alkylglycines in rat hippocampal neurons.N-烷基甘氨酸对大鼠海马神经元兴奋性毒性的神经保护作用。
Neuromolecular Med. 2002;2(3):271-80. doi: 10.1385/NMM:2:3:271.

本文引用的文献

1
Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).美金刚用于重度痴呆:9M-Best研究结果(美金刚治疗重度痴呆患者的获益与疗效)
Int J Geriatr Psychiatry. 1999 Feb;14(2):135-46. doi: 10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0.
2
A simple model for the prediction of blood-brain partitioning.
Int J Pharm. 2000 May 25;201(2):239-47. doi: 10.1016/s0378-5173(00)00422-1.
3
Insights from mouse models into the molecular basis of neurodegeneration.小鼠模型对神经退行性变分子基础的见解。
Annu Rev Physiol. 2000;62:779-802. doi: 10.1146/annurev.physiol.62.1.779.
4
Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.纹状体机制与帕金森氏体征及运动并发症的发病机制
Ann Neurol. 2000 Apr;47(4 Suppl 1):S122-9; discussion S129-30.
5
Neural science: a century of progress and the mysteries that remain.神经科学:百年进展与未解之谜
Cell. 2000 Feb 18;100 Suppl:S1-55.
6
Blood-brain barrier biology and methodology.血脑屏障生物学与方法学。
J Neurovirol. 1999 Dec;5(6):556-69. doi: 10.3109/13550289909021285.
7
Mixture-based synthetic combinatorial libraries.基于混合物的合成组合文库。
J Med Chem. 1999 Sep 23;42(19):3743-78. doi: 10.1021/jm990174v.
8
The changing landscape of ischaemic brain injury mechanisms.缺血性脑损伤机制的不断变化态势。
Nature. 1999 Jun 24;399(6738 Suppl):A7-14. doi: 10.1038/399a007.
9
Engineering the NMDA receptor channel lining.
Methods Mol Biol. 1999;128:167-78. doi: 10.1385/1-59259-683-5:167.
10
Structures of the M2 channel-lining segments from nicotinic acetylcholine and NMDA receptors by NMR spectroscopy.通过核磁共振光谱法测定烟碱型乙酰胆碱受体和NMDA受体的M2通道内衬片段的结构。
Nat Struct Biol. 1999 Apr;6(4):374-9. doi: 10.1038/7610.